Anti-mouse PD-1 (CD279)-InVivo

目录号：A2122         批次号: A212235

       克隆号：RMP1-14

打印

Anti-mouse PD-1 (CD279)-InVivo(克隆号：RMP1-14)能够与小鼠PD-1（programmed death-1）也称为 CD279 发生反应。 PD-1 是由属于 Ig 超家族 CD28 家族的 Pdcd1 基因编码的 50-55 kDa 细胞表面受体。

抗体信息

克隆号 RMP1-14
配制 PBS Buffer, PH 7.4
推荐同型对照 Rat IgG2a, κ
来源 CHO
储存条件
(自收到货起)		 Store the undiluted solution at 4°C and avoid freeze-thaw cycle
除菌 0.2 μM filtered
纯度 99%
蛋白浓度 9.14 mg/mL
内毒素 ＜1 EU/mg

客户使用selleck产品的实验数据

Anti-mouse PD-1 (CD279)-InVivo在文献中得到引用

Ultra-high dose rate radiotherapy overcomes radioresistance in head and neck squamous cell carcinoma [ Signal Transduct Target Ther, 2025, 10(1):82] PubMed: 40032871
Massively parallel interrogation of human functional variants modulating cancer immunosurveillance [ Signal Transduct Target Ther, 2025, 10(1):88] PubMed: 40102418
Nanosized Shikonin Disrupts Tumor-Cell Mismatch Repair and Synergizes with Manganese to Sensitize Squamous Carcinoma to Immunotherapy [ ACS Nano, 2025, 19(14):13889-13905] PubMed: 40190094
The mechanism of YAP/TAZ transactivation and dual targeting for cancer therapy [ Nat Commun, 2025, 16(1):3855] PubMed: 40274828
USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment [ Cancer Immunol Res, 2025, 10.1158/2326-6066.CIR-24-1194] PubMed: 40323348
Tetrandrine augments melanoma cell immunogenicity via dual inhibition of autophagic flux and proteasomal activity enhancing MHC-I presentation [ Acta Pharmacol Sin, 2025, 10.1038/s41401-025-01507-9] PubMed: 40016522
Dynamic evolution and antitumor mechanisms of CXCR6+CD8+ T cells in small cell lung cancer treated with low-dose radiotherapy and immunotherapy [ J Transl Med, 2025, 23(1):453] PubMed: 40247265
Escherichia coli combination with PD-1 blockade synergistically enhances immunotherapy in glioblastoma multiforme by regulating the immune cells [ J Transl Med, 2025, 23(1):164] PubMed: 39920704
Resveratrol alleviates testicular toxicity induced by anti-PD-1 through regulating the NRF2-SLC7A11-GPX4 pathway [ Front Immunol, 2025, 16:1529991] PubMed: 40145083
PD-L1-CD80 interactions are required for intracellular signaling necessary for dendritic cell migration [ Sci Adv, 2025, 11(5):eadt3044] PubMed: 39879305

禁止用于人体及治疗！